Describes the journey of a medtech startup in India. Talks about different stages of Idea generation to Validation to Market and funding opportunities for each stage. Presentation given to students, entrepreneurs at various forums by CEO.
14. Axio Biosolutions
• Started as incubated project in ’07 at NirmaLabs
• Focus areas: Biomaterial based woundcare
– Hemostasis
– Infection control
– Wound healing
• axiostat – India’s First Emergency hemostat.
15. DEATH DUE TO TRAUMA
Traumatic Bleeding Civilian
-- 42% CNS
Military
-- 47% Hemorrhage
-- 39% Hemorrhage -- 36% CNS
-- 12% Multiple -- 13% Multiple
-- 7% MOF -- 4% MOF
Sauaia et al. J Trauma 1995:38; 185-192
Bellamy RF. Mil Med 1984: 149: 55-62
15
16. Stops profuse bleeding within minutes
Made of natural biomaterials
Non-toxic, Biocompatible
Applications: Lacerations, Abrasions,
Punctures, Arterial/venous ruptures,
Intravascular Procedures
Effective for coagulopathic victims
Durable – 3 yrs Shelf life
**Trademark under registration
16
* Patent Pending
17. Timeline
2007 - Incubation & Product dev. starts
2008 - Proof of concept
- Axio Biosolutions Pvt. Ltd. established
- Provisional patent filed
2009 - Preclinical safety studies
- Preclinical efficacy study
- MSME Foundation grant
2010 - Complete patent filed
- GMP Manufacturing
- Regulation approval submission
- VC Investment
2011 - Clinical studies
2012 - Regulatory clearance for mfg and marketing